These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 36974635)

  • 1. Identification of m6A-associated LncRNAs as predict factors for the immune infiltration and prognosis of thyroid cancer.
    Su Y; Xu B; Li J; Shen Q; Lei Z; Ma M; Zhang F; Hu T
    Ann Med; 2023 Dec; 55(1):1298-1316. PubMed ID: 36974635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of m6A-related lncRNAs for thyroid cancer recurrence.
    Wang X; Su D; Wei Y; Liu S; Gao S; Tian H; Wei W
    Gland Surg; 2023 Jan; 12(1):39-53. PubMed ID: 36761480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the prognostic significance and potential mechanisms of lncRNAs associated with m6A methylation in papillary thyroid carcinoma.
    Huang Y; Li X; Chen W; He Y; Wu S; Li X; Hou B; Wang S; He Y; Jiang H; Lun Y; Zhang J
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108286. PubMed ID: 34735975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
    Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C
    BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of m6A-related lncRNAs LINC02471 and DOCK9-DT as potential biomarkers for thyroid cancer.
    Chen D; Zhao H; Guo Z; Dong Z; Yu Y; Zheng J; Ma Y; Sun H; Zhang Q; Zhang J; He Y; Song T
    Int Immunopharmacol; 2024 May; 133():112050. PubMed ID: 38636370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis and prognostic significance of tumour immune infiltrates and immune microenvironment of m6A-related lncRNAs in patients with gastric cancer.
    Huang J; Song J; Li X; Liu S; Huang W; Shen Z; Cheng Y; Kou S; Gao Z; Tian Y; Hu J
    BMC Med Genomics; 2022 Jul; 15(1):164. PubMed ID: 35879790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma.
    Qiu Y; Wang X; Fan Z; Zhan S; Jiang X; Huang J
    Immun Inflamm Dis; 2021 Dec; 9(4):1596-1612. PubMed ID: 34432955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
    Pang R; Yang S
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of m6A RNA Methylation-Related lncRNAs in the Prognosis and Tumor Immune Microenvironment of Papillary Thyroid Carcinoma.
    Wang W; Shen C; Zhao Y; Sun B; Qiu X; Yin S; Chen J; Li X
    Front Cell Dev Biol; 2021; 9():719820. PubMed ID: 35047491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and Validation of an Immune-Related lncRNA Prognosis Model for Thyroid Cancer.
    Li Z; Wang H; Deng X; Zhang J; Wang L; Tang W; You W; Nian W
    Comb Chem High Throughput Screen; 2022; 25(13):2217-2227. PubMed ID: 35209814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of prognostic m6A-related lncRNA and mRNA model in thyroid cancer.
    Zhu Y; Yu T; Huang J; Ma X; Shen T; Li A; Yue R
    Am J Cancer Res; 2022; 12(7):3259-3279. PubMed ID: 35968348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma.
    Hu Y; Chen Y
    Sci Rep; 2021 Sep; 11(1):17844. PubMed ID: 34497315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid cancer risk prediction model using m6A RNA methylation regulators: integrated bioinformatics analysis and histological validation.
    Zhou W; Lin J; Liu J; Zhang R; Fan A; Xie Q; Hong L; Fan D
    Aging (Albany NY); 2023 Feb; 15(3):846-865. PubMed ID: 36791151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma.
    Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J
    Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of an N6-methyladenosine lncRNA- and immune cell infiltration-related prognostic model in colorectal cancer.
    Yu ZL; Zhu ZM
    Protoplasma; 2022 Jul; 259(4):1029-1045. PubMed ID: 34734333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Five m6A-Related lncRNA Genes as Prognostic Markers for Endometrial Cancer Based on TCGA Database.
    Shan L; Lu Y; Xiang CC; Zhu X; Zuo ED; Cheng X
    J Immunol Res; 2022; 2022():2547029. PubMed ID: 35571565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and validation of a novel prognostic model for thyroid cancer based on N7-methylguanosine modification-related lncRNAs.
    Zhou Y; Dai X; Lyu J; Li Y; Bao X; Deng F; Liu K; Cui L; Cheng L
    Medicine (Baltimore); 2022 Oct; 101(42):e31075. PubMed ID: 36281116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of lactate metabolism-related LncRNAs in the prognosis, mutation, and tumor microenvironment of papillary thyroid cancer.
    Xia M; Wang S; Wang L; Mei Y; Tu Y; Gao L
    Front Endocrinol (Lausanne); 2023; 14():1062317. PubMed ID: 37025405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.